packageErdafitinib

erdafitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Erdafitinib is a protein kinase inhibitor used to treat transitional cell carcinoma, a cancer of the urinary tract. It is authorised in the European Union and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q27077213 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:erdafitinib
ATC codes:L01EN01
DrugBank:DB12147
PubChem CID:67462786
Wikidata:Q27077213
formula:C25H30N6O2
molar mass:446.555 g/mol (PubChem CID 67462786)
logP:3.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown